Hodgkin's Disease

Jürgen Dunst; Rolf Sauer; Alan Saven; Walter J. Urba; Dan L. Longo

doi:10.1056/NEJM199208133270716

Hodgkin's Disease

Jürgen Dunst, Rolf Sauer, Alan Saven, Walter J. Urba, Dan L. Longo

Clinic of Radiotherapy

Abstract

To the Editor: In their excellent review article on Hodgkin's disease (March 5 issue),¹ Urba and Longo recommend that radiotherapy should be delivered only by an experienced radiation oncologist because the “treatment outcome may vary in relation to the radiation oncologist's degree of experience.” They do not make comparable recommendations for the administration of combination chemotherapy. However, it is highly unlikely that the medical oncologist's experience will not influence treatment results. Moreover, acute life-threatening toxicity is as frequent or more frequent after chemotherapy than after radiotherapy. We would therefore recommend that the medical oncologist who treats a patient with Hodgkin's…

Original language	English
Journal	New England Journal of Medicine
Volume	327
Issue number	7
Pages (from-to)	499-500
Number of pages	2
ISSN	0028-4793
DOIs	https://doi.org/10.1056/NEJM199208133270716
Publication status	Published - 13.08.1992

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJM199208133270716

Cite this

@article{144a90ef535d41108eb94d357d318566,

title = "Hodgkin's Disease",

abstract = "To the Editor: In their excellent review article on Hodgkin's disease (March 5 issue),1 Urba and Longo recommend that radiotherapy should be delivered only by an experienced radiation oncologist because the “treatment outcome may vary in relation to the radiation oncologist's degree of experience.” They do not make comparable recommendations for the administration of combination chemotherapy. However, it is highly unlikely that the medical oncologist's experience will not influence treatment results. Moreover, acute life-threatening toxicity is as frequent or more frequent after chemotherapy than after radiotherapy. We would therefore recommend that the medical oncologist who treats a patient with Hodgkin's…",

author = "J{\"u}rgen Dunst and Rolf Sauer and Alan Saven and Urba, {Walter J.} and Longo, {Dan L.}",

year = "1992",

month = aug,

day = "13",

doi = "10.1056/NEJM199208133270716",

language = "English",

volume = "327",

pages = "499--500",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "7",

}

TY - JOUR

T1 - Hodgkin's Disease

AU - Dunst, Jürgen

AU - Sauer, Rolf

AU - Saven, Alan

AU - Urba, Walter J.

AU - Longo, Dan L.

PY - 1992/8/13

Y1 - 1992/8/13

N2 - To the Editor: In their excellent review article on Hodgkin's disease (March 5 issue),1 Urba and Longo recommend that radiotherapy should be delivered only by an experienced radiation oncologist because the “treatment outcome may vary in relation to the radiation oncologist's degree of experience.” They do not make comparable recommendations for the administration of combination chemotherapy. However, it is highly unlikely that the medical oncologist's experience will not influence treatment results. Moreover, acute life-threatening toxicity is as frequent or more frequent after chemotherapy than after radiotherapy. We would therefore recommend that the medical oncologist who treats a patient with Hodgkin's…

AB - To the Editor: In their excellent review article on Hodgkin's disease (March 5 issue),1 Urba and Longo recommend that radiotherapy should be delivered only by an experienced radiation oncologist because the “treatment outcome may vary in relation to the radiation oncologist's degree of experience.” They do not make comparable recommendations for the administration of combination chemotherapy. However, it is highly unlikely that the medical oncologist's experience will not influence treatment results. Moreover, acute life-threatening toxicity is as frequent or more frequent after chemotherapy than after radiotherapy. We would therefore recommend that the medical oncologist who treats a patient with Hodgkin's…

UR - http://www.scopus.com/inward/record.url?scp=1642504762&partnerID=8YFLogxK

U2 - 10.1056/NEJM199208133270716

DO - 10.1056/NEJM199208133270716

M3 - Letters

C2 - 1625746

AN - SCOPUS:1642504762

SN - 0028-4793

VL - 327

SP - 499

EP - 500

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Hodgkin's Disease

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this